This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Ocugen Inc. (OCGN) dropped 0.26% to $7.53 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.85% to 4,480.70 and the Dow Jones Industrial Average rising 0.68% to 34,814.39. This was the stock's second consecutive day of losses. Ocugen Inc. closed $11.24 short of its 52-week high ($18.77), which the company achieved on February 8th.
The stock demonstrated a mixed performance when compared to some of its competitors Wednesday, as Adverum Biotechnologies Inc. (ADVM) remained unchanged, Ocular Therapeutix Inc. (OCUL) fell 3.74% to $10.30, and Kodiak Sciences Inc. (KOD) rose 0.65% to $94.52. Trading volume (15.2 M) eclipsed its 50-day average volume of 14.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled September 15, 2021.
(END) Dow Jones Newswires
September 15, 2021 17:13 ET (21:13 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.